Breaking News Instant updates and real-time market news.

EVRC

Evercel, Inc

$2.00 /

-0.2 (-9.09%)

08:58
09/17/21
09/17
08:58
09/17/21
08:58

Evercel issues shareholder letter prior to Annual Meeting

Evercel issued a letter to shareholders, providing an update on the Company's business as it approaches its Annual Meeting. The letter read in part, "It has been an active period at Evercel and we are very excited about our holdings, positioning and path forward. We are writing to provide some business highlights ahead of the Company's Annual Meeting, which will be held on October 7, 2021 at 10:00am ET. Put plainly, we have assembled a great asset base, which we believe is valuable now and will be more so in the future. Since 2012, we have grown $18 million of cash into approximately $80 million worth of assets, after fees. Importantly, we believe there is significant incremental, embedded value in these assets that is yet to be recognized by the market, as demonstrated by the mismatch between the value of Evercel's assets and Evercel's current market capitalization. We are disappointed that to date the Company's stock price has not appreciated consistent with the increase in value of Evercel's underlying investments. The Board will be taking important steps to increase communication with shareholders, as described below. Additionally, we are confident that our application to be listed on the OTCQX market and our recent additions to the Board will help us better harness that value...If you haven't already, you soon will be receiving a proxy statement from the Company regarding the Annual Meeting. In the proxy, we provide background information on our two highly qualified nominees for election to the Board, Patrick McGeehin and Richard Perkins. We believe Mr. McGeehin and Mr. Perkins warrant your support as both have been instrumental on the Board in helping define the Company's path forward, and we are confident that, if reelected, Mr. Perkins and Mr. McGeehin will strengthen leadership's efforts to help Evercel's share price better reflect the Company's true value. As noted above, Mr. McGeehin, who recently joined the Board, has valuable accounting and consulting experience, and he also has been a shareholder in Evercel for over a decade with a meaningful number of shares. Mr. Perkins brings with him decades of management and investing experience that we believe will be additive to Evercel's efforts to drive value creation. You can find additional information about their qualifications in the proxy statement. A proxy card for you to vote your shares in support is also included with the proxy...Finally, we also wanted to let you know that as we approach October 7th, you may be contacted by our proxy firm, Okapi Partners. We encourage you to speak with them, as they can answer any questions you may have and provide accurate information about the nominees, management and the existing Board so you can confidently vote your shares...We believe the past year has been a very productive one for your company, Evercel, and one that has positioned us well for the future. We trust that you are excited about our prospects as we are, and we hope to have your support at the Annual Meeting. We plan to build on the success and continue seeking out compelling opportunities to increase the value and share price of your company."

OTHER BREAKING NEWS FROM THE FLY

Recommendations
Amedisys' Contessa finalizing '9-figure revenue contract,' says Jefferies » 07:51
06/27/22
06/27
07:51
06/27/22
07:51
AMED

Amedisys

$115.40 /

+0.11 (+0.10%)

After having hosted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMED Amedisys
$115.40 /

+0.11 (+0.10%)

AMED Amedisys
$115.40 /

+0.11 (+0.10%)

06/22/22 Benchmark
Benchmark doesn't expect proposed Medicare home health cut to make final rule
06/21/22 BofA
Amedisys cut to Underperform at BofA after CMS proposal on home health rates
06/21/22 BofA
Amedisys downgraded to Underperform from Neutral at BofA
06/21/22 Deutsche Bank
Amedisys price target lowered to $175 from $210 at Deutsche Bank
AMED Amedisys
$115.40 /

+0.11 (+0.10%)

Hot Stocks
Cronos Group announces partnership with Geocann » 07:49
06/27/22
06/27
07:49
06/27/22
07:49
CRON

Cronos Group

$3.11 /

+0.155 (+5.25%)

Cronos Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

05/11/22 CIBC
CIBC upgrades Cronos to buy on 'multiple reasons for optimism'
05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
05/11/22 Canaccord
Cronos Group upgraded to Hold from Sell at Canaccord
CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

Hot Stocks
Freyr announces Minister of Trade, Industry launched Norwegian battery strategy » 07:45
06/27/22
06/27
07:45
06/27/22
07:45
FREY

Freyr Battery

$6.93 /

-0.005 (-0.07%)

FREYR Battery welcomes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FREY Freyr Battery
$6.93 /

-0.005 (-0.07%)

FREY Freyr Battery
$6.93 /

-0.005 (-0.07%)

06/20/22 Goldman Sachs
Freyr Battery initiated with a Neutral at Goldman Sachs
03/17/22 US Capital Advisors
Freyr Battery initiated with a Buy at US Capital Advisors
01/26/22 Clarksons Platou
Freyr Battery initiated with a Buy at Clarksons Platou
01/04/22 Morgan Stanley
Ferrari replacing GM as Morgan Stanley's new 'Top Pick' in U.S. autos
FREY Freyr Battery
$6.93 /

-0.005 (-0.07%)

FREY Freyr Battery
$6.93 /

-0.005 (-0.07%)

FREY Freyr Battery
$6.93 /

-0.005 (-0.07%)

Conference/Events
Relay Therapeutics to hold virtual event » 07:45
06/27/22
06/27
07:45
06/27/22
07:45
RLAY

Relay Therapeutics

$20.87 /

+1.87 (+9.84%)

Virtual Investor and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RLAY Relay Therapeutics
$20.87 /

+1.87 (+9.84%)

RLAY Relay Therapeutics
$20.87 /

+1.87 (+9.84%)

06/06/22 Jefferies
Relay Therapeutics initiated with an Underperform at Jefferies
05/10/22 H.C. Wainwright
Relay Therapeutics price target lowered to $47 from $54 at H.C. Wainwright
05/09/22 JMP Securities
Relay Therapeutics price target lowered to $35 from $50 at JMP Securities
02/01/22 Berenberg
Relay Therapeutics initiated with a Buy at Berenberg
RLAY Relay Therapeutics
$20.87 /

+1.87 (+9.84%)

  • 13
    Oct
Recommendations
Altria Group price target lowered to $45 from $56 at Cowen » 07:43
06/27/22
06/27
07:43
06/27/22
07:43
MO

Altria Group

$43.41 /

+0.905 (+2.13%)

Cowen analyst Vivien Azer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MO Altria Group
$43.41 /

+0.905 (+2.13%)

MO Altria Group
$43.41 /

+0.905 (+2.13%)

06/24/22 Morgan Stanley
Altria Group upgraded to Equal Weight from Underweight at Morgan Stanley
06/22/22 Goldman Sachs
Altria selloff overdone on potential FDA action on JUUL, says Goldman Sachs
06/22/22 Stifel
Potential ban of JUUL vapor products 'clear negative' for Altria, says Stifel
06/22/22 Jefferies
FDA lowered nicotine rule likely to take many years to implement, says Jefferies
MO Altria Group
$43.41 /

+0.905 (+2.13%)

MO Altria Group
$43.41 /

+0.905 (+2.13%)

MO Altria Group
$43.41 /

+0.905 (+2.13%)

MO Altria Group
$43.41 /

+0.905 (+2.13%)

Recommendations
Rockwell Automation price target lowered to $260 from $277 at Morgan Stanley » 07:42
06/27/22
06/27
07:42
06/27/22
07:42
ROK

Rockwell Automation

$201.07 /

+3.735 (+1.89%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ROK Rockwell Automation
$201.07 /

+3.735 (+1.89%)

ROK Rockwell Automation
$201.07 /

+3.735 (+1.89%)

05/24/22 Barclays
Rockwell Automation price target lowered to $200 from $220 at Barclays
05/10/22 HSBC
Rockwell Automation price target lowered to $240 from $293 at HSBC
05/05/22 JPMorgan
Rockwell Automation price target lowered to $200 from $220 at JPMorgan
05/04/22 Oppenheimer
Rockwell Automation price target lowered to $290 from $360 at Oppenheimer
ROK Rockwell Automation
$201.07 /

+3.735 (+1.89%)

ROK Rockwell Automation
$201.07 /

+3.735 (+1.89%)

Recommendations
Roche price target lowered to $48 from $58 at Cowen » 07:41
06/27/22
06/27
07:41
06/27/22
07:41
RHHBY

Roche

$41.64 /

+1.63 (+4.07%)

Cowen analyst Steve Scala…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$41.64 /

+1.63 (+4.07%)

RHHBY Roche
$41.64 /

+1.63 (+4.07%)

06/02/22 Piper Sandler
Piper ups Repare Therapeutics target after 'great deal' with Roche
05/19/22 Credit Suisse
Roche price target lowered to CHF 350 from CHF 370 at Credit Suisse
05/13/22 Jefferies
Roche downgraded to Hold from Buy at Jefferies
05/12/22 Morgan Stanley
Roche price target lowered to CHF 370 from CHF 395 at Morgan Stanley
RHHBY Roche
$41.64 /

+1.63 (+4.07%)

RHHBY Roche
$41.64 /

+1.63 (+4.07%)

RHHBY Roche
$41.64 /

+1.63 (+4.07%)

Hot Stocks
Accenture to acquire XtremeEDA, terms not disclosed » 07:39
06/27/22
06/27
07:39
06/27/22
07:39
ACN

Accenture

$299.36 /

+13.3 (+4.65%)

Accenture "has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$299.36 /

+13.3 (+4.65%)

ACN Accenture
$299.36 /

+13.3 (+4.65%)

06/25/22 Barclays
Accenture price target lowered to $370 from $455 at Barclays
06/24/22 RBC Capital
Accenture price target lowered to $357 from $435 at RBC Capital
06/24/22 Cowen
Accenture price target lowered to $325 from $330 at Cowen
06/24/22 Baird
Accenture price target lowered to $310 from $340 at Baird
ACN Accenture
$299.36 /

+13.3 (+4.65%)

ACN Accenture
$299.36 /

+13.3 (+4.65%)

ACN Accenture
$299.36 /

+13.3 (+4.65%)

Recommendations
Merck price target raised to $102 from $95 at Cowen » 07:39
06/27/22
06/27
07:39
06/27/22
07:39
MRK

Merck

$93.22 /

+1.14 (+1.24%)

, SGEN

Seagen

$179.14 /

+5.07 (+2.91%)

Cowen analyst Boris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$93.22 /

+1.14 (+1.24%)

SGEN Seagen
$179.14 /

+5.07 (+2.91%)

MRK Merck
$93.22 /

+1.14 (+1.24%)

06/24/22 Mizuho
Merck deal would add 'novel and validated technology,' says Mizuho
06/21/22 Oppenheimer
Seagen price target raised to $208 from $160 at Oppenheimer
04/12/22 Barclays
Merck price target raised to $97 from $94 at Barclays
04/11/22 H.C. Wainwright
Rubius Therapeutics price target lowered to $15 from $40 at H.C. Wainwright
SGEN Seagen
$179.14 /

+5.07 (+2.91%)

06/24/22 Mizuho
Merck deal would add 'novel and validated technology,' says Mizuho
06/23/22 BMO Capital
Seagen initiated with a Market Perform at BMO Capital
06/21/22 Morgan Stanley
Seagen named 'Catalyst Driven Idea' at Morgan Stanley
06/21/22 Oppenheimer
Seagen price target raised to $208 from $160 at Oppenheimer
MRK Merck
$93.22 /

+1.14 (+1.24%)

SGEN Seagen
$179.14 /

+5.07 (+2.91%)

MRK Merck
$93.22 /

+1.14 (+1.24%)

SGEN Seagen
$179.14 /

+5.07 (+2.91%)

MRK Merck
$93.22 /

+1.14 (+1.24%)

SGEN Seagen
$179.14 /

+5.07 (+2.91%)

MRK Merck
$93.22 /

+1.14 (+1.24%)

Hot Stocks
Clover's COVID vaccine candidate shows 'strong' neutralization against variant » 07:39
06/27/22
06/27
07:39
06/27/22
07:39
DVAX

Dynavax

$12.34 /

+0.07 (+0.57%)

China's Clover…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DVAX Dynavax
$12.34 /

+0.07 (+0.57%)

DVAX Dynavax
$12.34 /

+0.07 (+0.57%)

01/05/22 Goldman Sachs
Goldman reinstates Dynavax at Buy, sees value creation from COVID platform
12/29/21 H.C. Wainwright
Dynavax price target raised to $28 from $23 at H.C. Wainwright
08/31/21 H.C. Wainwright
Dynavax price target raised to $23 from $20 at H.C. Wainwright
08/05/21 Goldman Sachs
Dynavax initiated with a Buy at Goldman Sachs
DVAX Dynavax
$12.34 /

+0.07 (+0.57%)

DVAX Dynavax
$12.34 /

+0.07 (+0.57%)

Hot Stocks
TG Therapeutics presents exploratory analyses from ublituximab in MS trial » 07:38
06/27/22
06/27
07:38
06/27/22
07:38
TGTX

TG Therapeutics

$4.39 /

-0.235 (-5.08%)

TG Therapeutics …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGTX TG Therapeutics
$4.39 /

-0.235 (-5.08%)

TGTX TG Therapeutics
$4.39 /

-0.235 (-5.08%)

06/13/22 B. Riley
TG Therapeutics price target lowered to $17 from $23 at B. Riley
05/20/22 BofA
BofA starts TG Therapeutics at Underperform, sees difficult commercial setup
05/20/22 BofA
TG Therapeutics initiated with an Underperform at BofA
04/19/22 B. Riley
TG Therapeutics application withdrawal 'clearing event,' says B. Riley
TGTX TG Therapeutics
$4.39 /

-0.235 (-5.08%)

TGTX TG Therapeutics
$4.39 /

-0.235 (-5.08%)

TGTX TG Therapeutics
$4.39 /

-0.235 (-5.08%)

Recommendations
Televisa price target lowered to $13 from $15.50 at JPMorgan » 07:38
06/27/22
06/27
07:38
06/27/22
07:38
TV

Televisa

$8.71 /

+0.34 (+4.06%)

JPMorgan analyst Marcelo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TV Televisa
$8.71 /

+0.34 (+4.06%)

06/01/22 Goldman Sachs
Televisa reinstated with a Neutral at Goldman Sachs
03/23/22 Barclays
Televisa upgraded to Equal Weight from Underweight at Barclays
03/18/22 JPMorgan
America Movil downgraded to Neutral from Overweight at JPMorgan
03/18/22 JPMorgan
Televisa resumed with Overweight from Neutral at JPMorgan
TV Televisa
$8.71 /

+0.34 (+4.06%)

Recommendations
Copa Holdings price target lowered to $76 from $90 at JPMorgan » 07:38
06/27/22
06/27
07:38
06/27/22
07:38
CPA

Copa Holdings

$63.84 /

+2.61 (+4.26%)

JPMorgan analyst Fernando…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPA Copa Holdings
$63.84 /

+2.61 (+4.26%)

CPA Copa Holdings
$63.84 /

+2.61 (+4.26%)

05/13/22 Barclays
Barclays double upgrades Copa Holdings on improving operations
05/13/22 Barclays
Copa Holdings upgraded to Overweight from Underweight at Barclays
04/13/22 Raymond James
Copa Holdings price target lowered to $110 from $115 at Raymond James
02/23/22 Barclays
Copa Holdings price target raised to $96 from $82 at Barclays
CPA Copa Holdings
$63.84 /

+2.61 (+4.26%)

Hot Stocks
DocGo to be added to Russell 2000 Index » 07:37
06/27/22
06/27
07:37
06/27/22
07:37
DCGO

DocGo

$7.11 /

-0.39 (-5.20%)

DocGo announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DCGO DocGo
$7.11 /

-0.39 (-5.20%)

DCGO DocGo
$7.11 /

-0.39 (-5.20%)

05/11/22 Canaccord
DocGo price target lowered to $10 from $13 at Canaccord
04/19/22 Deutsche Bank
DocGo initiated with a Buy at Deutsche Bank
01/19/22 Stifel
DocGo initiated with a Buy at Stifel
01/04/22 Northland
DocGo named a top pick for 2022 at Northland
DCGO DocGo
$7.11 /

-0.39 (-5.20%)

DCGO DocGo
$7.11 /

-0.39 (-5.20%)

Hot Stocks
BridgeBio announces data for for BBP-711 to treat recurrent kidney stone formers » 07:35
06/27/22
06/27
07:35
06/27/22
07:35
BBIO

BridgeBio

$9.24 /

+0.175 (+1.93%)

BridgeBio Pharma …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBIO BridgeBio
$9.24 /

+0.175 (+1.93%)

BBIO BridgeBio
$9.24 /

+0.175 (+1.93%)

03/16/22 H.C. Wainwright
BridgeBio price target lowered to $22 from $24 at H.C. Wainwright
03/11/22 JPMorgan
BridgeBio price target lowered to $18 from $21 at JPMorgan
01/03/22 Piper Sandler
Alnylam upgraded to Overweight from Neutral at Piper Sandler
12/30/21 BofA
Alnylam remains top pick for 2022 at Bofa amid recent volatility
BBIO BridgeBio
$9.24 /

+0.175 (+1.93%)

BBIO BridgeBio
$9.24 /

+0.175 (+1.93%)

BBIO BridgeBio
$9.24 /

+0.175 (+1.93%)

Downgrade
Morgan Stanley downgrades Varonis to Equal Weight on slowing topline growth » 07:35
06/27/22
06/27
07:35
06/27/22
07:35
VRNS

Varonis

$34.92 /

+2.04 (+6.20%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRNS Varonis
$34.92 /

+2.04 (+6.20%)

VRNS Varonis
$34.92 /

+2.04 (+6.20%)

05:34 Today Morgan Stanley
Varonis downgraded to Equal Weight from Overweight at Morgan Stanley
05/23/22 Jefferies
Varonis price target lowered to $40 from $65 at Jefferies
05/10/22 Truist
Varonis price target lowered to $50 from $65 at Truist
05/03/22 Wedbush
Varonis price target lowered to $52 from $60 at Wedbush
VRNS Varonis
$34.92 /

+2.04 (+6.20%)

VRNS Varonis
$34.92 /

+2.04 (+6.20%)

Earnings
Stealth Biotherapeutics announces receipt of preliminary non-binding proposal » 07:34
06/27/22
06/27
07:34
06/27/22
07:34
MITO

Stealth Biotherapeutics

/

+

Stealth BioTherapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MITO Stealth Biotherapeutics
/

+

MITO Stealth Biotherapeutics
/

+

05/23/22 H.C. Wainwright
Stealth Biotherapeutics price target lowered to $1.50 from $4 at H.C. Wainwright
07/01/21 Maxim
Stealth Biotherapeutics initiated with a Buy at Maxim
07/01/21 Maxim
Stealth Biotherapeutics initiated with a Buy at Maxim
Hot Stocks
Foot Locker to divest team sales business » 07:33
06/27/22
06/27
07:33
06/27/22
07:33
FL

Foot Locker

$29.56 /

+0.53 (+1.83%)

Foot Locker announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FL Foot Locker
$29.56 /

+0.53 (+1.83%)

FL Foot Locker
$29.56 /

+0.53 (+1.83%)

05/24/22 Williams Trading
Foot Locker downgraded to Sell from Hold at Williams Trading
05/23/22 B. Riley
Foot Locker price target lowered to $33 from $34 at B. Riley
05/23/22 Deutsche Bank
Foot Locker price target raised to $32 from $30 at Deutsche Bank
05/23/22 Baird
Foot Locker price target raised to $32 from $30
FL Foot Locker
$29.56 /

+0.53 (+1.83%)

FL Foot Locker
$29.56 /

+0.53 (+1.83%)

FL Foot Locker
$29.56 /

+0.53 (+1.83%)

FL Foot Locker
$29.56 /

+0.53 (+1.83%)

Hot Stocks
Holley added to membership of the small-cap Russell 2000 Index » 07:33
06/27/22
06/27
07:33
06/27/22
07:33
HLLY

Holley

$10.21 /

+0.21 (+2.10%)

Holley was added as a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HLLY Holley
$10.21 /

+0.21 (+2.10%)

HLLY Holley
$10.21 /

+0.21 (+2.10%)

06/22/22 BofA
Holley initiated with a Buy at BofA
03/04/22 Jefferies
Holley assumed with a Buy rating, $20 price target at Jefferies
09/09/21 Truist
Truist starts Holley at Buy with positive view of secular growth attributes
09/09/21 Truist
Holley initiated with a Buy at Truist
HLLY Holley
$10.21 /

+0.21 (+2.10%)

  • 21
    Apr
HLLY Holley
$10.21 /

+0.21 (+2.10%)

Hot Stocks
Digital World Acquisition says Garelick to resign from board » 07:32
06/27/22
06/27
07:32
06/27/22
07:32
DWAC

Digital World Acquisition

$27.81 /

-0.06 (-0.22%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

Hot Stocks
Foot Locker to divest team sales business  07:32
06/27/22
06/27
07:32
06/27/22
07:32
FL

Foot Locker

$29.56 /

+0.53 (+1.83%)

 
ShowHide Related Items >><<
FL Foot Locker
$29.56 /

+0.53 (+1.83%)

FL Foot Locker
$29.56 /

+0.53 (+1.83%)

05/24/22 Williams Trading
Foot Locker downgraded to Sell from Hold at Williams Trading
05/23/22 B. Riley
Foot Locker price target lowered to $33 from $34 at B. Riley
05/23/22 Deutsche Bank
Foot Locker price target raised to $32 from $30 at Deutsche Bank
05/23/22 Baird
Foot Locker price target raised to $32 from $30
FL Foot Locker
$29.56 /

+0.53 (+1.83%)

FL Foot Locker
$29.56 /

+0.53 (+1.83%)

FL Foot Locker
$29.56 /

+0.53 (+1.83%)

FL Foot Locker
$29.56 /

+0.53 (+1.83%)

Hot Stocks
Aptose Biosciences appoints Fletcher Payne as SVP, CFO » 07:32
06/27/22
06/27
07:32
06/27/22
07:32
APTO

Aptose Biosciences

/

+

Aptose Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APTO Aptose Biosciences
/

+

APTO Aptose Biosciences
/

+

04/28/22 Cantor Fitzgerald
Aptose Biosciences assumed with an Overweight at Cantor Fitzgerald
12/20/21 Piper Sandler
Aptose Biosciences price target lowered to $3 from $7 at Piper Sandler
12/20/21 H.C. Wainwright
Aptose price target lowered to $12 from $14 at H.C. Wainwright
12/14/21 Alliance Global Partners
Aptose price target lowered to $8 from $12 at Alliance Global Partners
APTO Aptose Biosciences
/

+

Hot Stocks
Trump-linked SPAC Digital World reports receipt of grand jury subpoena » 07:31
06/27/22
06/27
07:31
06/27/22
07:31
DWAC

Digital World Acquisition

$27.81 /

-0.06 (-0.22%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

Hot Stocks
nCino names Chris Ainsworth as chief people officer » 07:31
06/27/22
06/27
07:31
06/27/22
07:31
NCNO

nCino

$37.19 /

+2.54 (+7.33%)

nCino announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NCNO nCino
$37.19 /

+2.54 (+7.33%)

NCNO nCino
$37.19 /

+2.54 (+7.33%)

06/02/22 Truist
nCino price target lowered to $70 from $80 at Truist
06/02/22 Needham
nCino price target lowered to $42 from $60 at Needham
06/02/22 Barclays
nCino price target raised to $39 from $38 at Barclays
06/02/22 KeyBanc
nCino price target lowered to $45 from $60 at KeyBanc
NCNO nCino
$37.19 /

+2.54 (+7.33%)

NCNO nCino
$37.19 /

+2.54 (+7.33%)

NCNO nCino
$37.19 /

+2.54 (+7.33%)

NCNO nCino
$37.19 /

+2.54 (+7.33%)

Hot Stocks
Stealth BioTherapeutics Corporation (ADS) trading halted, news pending  07:28
06/27/22
06/27
07:28
06/27/22
07:28
MITO

Stealth Biotherapeutics

/

+

 
ShowHide Related Items >><<
MITO Stealth Biotherapeutics
/

+

MITO Stealth Biotherapeutics
/

+

05/23/22 H.C. Wainwright
Stealth Biotherapeutics price target lowered to $1.50 from $4 at H.C. Wainwright
07/01/21 Maxim
Stealth Biotherapeutics initiated with a Buy at Maxim
07/01/21 Maxim
Stealth Biotherapeutics initiated with a Buy at Maxim

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.